Showing 1 - 19 results of 19 for search 'José Luis Poveda-Andrés', query time: 0.03s Refine Results
  1. 1
    Farewell open letter to SEFH members

    Farewell open letter to SEFH members by José Luis Poveda Andrés

    Published 2015-11-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Hazardous drugs levels in compounding area surfaces of Hospital Pharmacies Services: multicentric study

    Hazardous drugs levels in compounding area surfaces of Hospital Pharmacies Services: multicentric study by José Luis Poveda-Andrés, Silvia Valero-García

    Published 2018-07-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Biosimilars: old debates, new arguments

    Biosimilars: old debates, new arguments by José Luis Poveda-Andrés, Virginia Bosó-Ribelles

    Published 2015-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Implementation and results of a risk-sharing scheme for enzyme replacement therapy in lysosomal storage diseases

    Implementation and results of a risk-sharing scheme for enzyme replacement therapy in lysosomal storage diseases by María Dolores Edo-Solsona, José Luis Poveda-Andrés, Isidro Vitoria-Miñana

    Published 2020-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Analysing criteria for price and reimbursement of orphan drugs in Spain

    Analysing criteria for price and reimbursement of orphan drugs in Spain by Xavier Badia, Alicia Gil, José Luis Poveda-Andrés, John Shepherd, Marina Tort

    Published 2019-07-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Hazardous drugs: new challenges, new opportunities

    Hazardous drugs: new challenges, new opportunities by Silvia Valero García, Eduardo López Briz, Nieves Vila Clérigues, Jose Luis Poveda Andrés

    Published 2016-03-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Secondary hemophagocytic syndrome due to Peg-interferon administration

    Secondary hemophagocytic syndrome due to Peg-interferon administration by Jesús Ruiz Ramos, Esther Domingo Chiva, Carmen Planells Herrero, José Luis Poveda Andrés

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Monitoring the quality of the hospital pharmacoterapeutic process by sentinel patient program

    Monitoring the quality of the hospital pharmacoterapeutic process by sentinel patient program by María José Fernández-Megía, Matilde Merino Sanjuán, Isabel Font Noguera, José Luis Poveda Andrés

    Published 2018-03-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Reduction in alert fatigue in an assisted electronic prescribing system, through the Lean Six Sigma methodology

    Reduction in alert fatigue in an assisted electronic prescribing system, through the Lean Six Sigma methodology by Mª Jesús Cuéllar Monreal, Jorge Reig Aguado, Isabel Font Noguera, José Luis Poveda Andrés

    Published 2017-01-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Self-administration of Recombinant Human Growth Hormone with an Electronic Device: Clinical, Economic and Management Benefits of Objective Adherence Monitoring

    Self-administration of Recombinant Human Growth Hormone with an Electronic Device: Clinical, Economic and Management Benefits of Objective Adherence Monitoring by Zuleika Saz-Parkinson, Maria Del Sol Granados Alonso, Carmen Bouza, José Luis Poveda Andrés, José María Amate

    Published 2015-12-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    A new definition and refocus of pharmaceutical care: the Barbate Document

    A new definition and refocus of pharmaceutical care: the Barbate Document by Ramón Morillo-Verdugo, José Luis Poveda-Andrés, María de las Aguas Robustillo-Cortés, Miguel Ángel Calleja-Hernández

    Published 2020-07-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Impact of an antimicrobial stewardship program on critical haematological patients

    Impact of an antimicrobial stewardship program on critical haematological patients by Jesus Ruiz-Ramos, Juan Frasquet, Jose Luis Poveda-Andrés, Eva Romá, Álvaro Castellanos, Miguel Salavert-Lleti, Paula Ramirez

    Published 2017-07-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Interdisciplinary recommendations document to improve adherence in patients with chronic inflammatory diseases: Adhing recommendations

    Interdisciplinary recommendations document to improve adherence in patients with chronic inflammatory diseases: Adhing recommendations by Fernando Bermejo San José, Mireia Barceló Barceló-Bru, Miquel Ribera-Pibernat, José Luís Poveda-Andrés, Luciano Sanromán-Álvarez

    Published 2016-12-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Assessment of the quality of sample labelling for clinical research

    Assessment of the quality of sample labelling for clinical research by Pablo Pérez-Huertas, María Tordera-Baviera, Concepción Martínez-Nieto, Natalia Benito-Zazo, Ana García-Robles, José Luis Poveda-Andrés

    Published 2016-03-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    2019 SEFH National Survey: service portfolio, care activities, education and research in Spain’s hospital pharmacy departments

    2019 SEFH National Survey: service portfolio, care activities, education and research in Spain’s hospital pharmacy departments by Montserrat Pérez-Encinas, Ana Lozano-Blázquez, Javier García-Pellicer, Inmaculada Torre-Lloveras, José Luis Poveda-Andrés, Miguel Ángel Calleja-Hernández

    Published 2021-01-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    SEFH National Survey-2019: general characteristics, staffing, material resources and information systems in Spain’s hospital pharmacy departments

    SEFH National Survey-2019: general characteristics, staffing, material resources and information systems in Spain’s hospital pharmacy departments by Montserrat Pérez-Encinas, Ana Lozano-Blázquez, Javier García-Pellicer, Inmaculada Torre-Lloveras, José Luis Poveda-Andrés, Miguel Ángel Calleja-Hernández

    Published 2020-11-01
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement

    Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement by Miguel Ángel Calleja Hernández, Alicia Herrero Ambrosio, María Jesús Lamas Díaz, Julio Martínez Cutillas, Jose Luis Poveda Andrés, Belén Aragón

    Published 2017-01-01
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    Applying dose banding to the production of antineoplastic drugs: a narrative review of the literature

    Applying dose banding to the production of antineoplastic drugs: a narrative review of the literature by Pablo Pérez Huertas, Margarita Cueto Sola, Paloma Escobar Cava, Carmela Borrell García, Asunción Albert Marí, Eduardo López Briz, José Luis Poveda Andrés

    Published 2015-07-01
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH)

    Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Phar... by Silvia Valero-García, Eva González-Haba, Maria Queralt Gorgas-Torner, José María Alonso-Herreros, Ana Cristina Cercós Lletí, José Luis Poveda-Andrés, Miguel Ángel Calleja-Hernandez, Olga Delgado-Sánchez

    Published 2021-03-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: